⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16028 | 0.71 | — | — | |
| SCHEMBL10627283 | 0.71 | — | — | |
| SCHEMBL11142889 | 0.71 | — | — | |
| SCHEMBL8989569 | 0.71 | — | — | |
| SCHEMBL1482315 | 0.71 | — | — | |
| SCHEMBL25396888 | 0.71 | — | — | |
| SCHEMBL8398525 | 0.71 | — | — | |
| SCHEMBL10530246 | 0.71 | — | — | |
| SCHEMBL11287416 | 0.71 | — | — | |
| SCHEMBL2973857 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281502-A1 | NEW DRUG APPLICATION | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2025-09-11 | — | — | US | claimed |
| CN-110490421-B | Fuzzy C-means clustering-based small and medium hydropower station capacity configuration method in microgrid | 广东工业大学 | 2022-11-22 | — | — | CN | claimed |
| EP-4071140-A1 | CFTR REGULATORS AND METHODS OF USE THEREOF | The Regents of The University of California (US) | 2022-10-12 | — | — | EP | claimed |
| CN-114026089-B | Substituted naphthalimides and uses thereof | UCL商业有限责任公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4548919-A2 | SUBSTITUTED NAPHTHALENE DIIMIDES AND THEIR USE | UCL Business Ltd (GB) | 2025-05-07 | — | — | EP | disclosed |
| US-20250129065-A1 | SUBSTITUTED NAPHTHALENE DIIMIDES AND THEIR USE | UCL BUSINESS LTD (GB) | 2025-04-24 | — | — | US | disclosed |
| EP-3969451-B1 | SUBSTITUTED NAPHTHALENE DIIMIDES AND THEIR USE | UCL BUSINESS LTD (GB) | 2025-02-12 | — | — | EP | disclosed |
| WO-2025003680-A1 | METHOD FOR IDENTIFYING SPECIFIC CANCER PATIENT SUBGROUPS AND NOVEL CANCER THERAPY FOR SPECIFIC CANCER PATIENT SUBGROUPS | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2025-01-02 | — | — | WO | disclosed |
| EP-4349368-A1 | THERAPY USING COMBINATION OF ANTI-CD26 ANTIBODY AND IMMUNE CHECKPOINT INHIBITOR | Y'S AC Co., Ltd. (JP) | 2024-04-10 | — | — | EP | disclosed |
| CN-116832081-A | Pharmaceutical composition for preventing or treating diabetic complications and angioedema comprising natural mixture extract as active ingredient | 韩国韩医学研究院 | 2023-10-03 | — | — | CN | disclosed |
| US-20230212166-A1 | SUBSTITUTED NAPHTHALENE DIIMIDES AND THEIR USE | UCL BUSINESS LTD (GB) | 2023-07-06 | — | — | US | disclosed |
| US-11560380-B2 | Substituted naphthalene diimides and their use | UCL BUSINESS LTD (GB) | 2023-01-24 | — | — | US | disclosed |
| CN-115529817-A | Vaccine and use thereof to induce an immune response against SARS-COV2 | 吉奥瓦科斯公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-110490421-B | Fuzzy C-means clustering-based small and medium hydropower station capacity configuration method in microgrid | 广东工业大学 | 2022-11-22 | — | — | CN | disclosed |
| US-11484562-B2 | Composition for preventing or treating obesity comprising natural mixture extracts | KOREA INSTITUTE OF ORIENTAL MEDICINE (KR) | 2022-11-01 | — | — | US | disclosed |
| US-20220220108-A1 | SUBSTITUTED NAPHTHALENE DIIMIDES AND THEIR USE | UCL BUSINESS LTD (GB) | 2022-07-14 | — | — | US | disclosed |